Back to blog
Signal 18 Oct 2026 · 7 min read

Empirica Signal: Market Health, 18 Oct 2026

This week's reading: selling eases, but no reversal yet

The Nifty Smallcap 250 ended a 5-week losing streak, closing up 0.36% at 17,638 on Friday. This is not a trend reversal. It shows a little strength and less selling pressure. The index is still below its 50-day average, so the medium-term trend remains weak.

Market condition this week: Condition 4, no fresh money. We remain very selective with fresh money.

Level we track

Value (16 Oct 2026 close)

Index vs this level

What it tells us

Index close

17,638

—

Up 0.36% this week; 4.9% below its 52-week high of 18,551

5-day average

17,740

0.6% below

Very short term

10-day average

17,724

0.5% below

Short term: index below it, so condition 4

50-day average

18,157

2.9% below

Medium-term trend still under pressure

200-day average

16,942

4.1% above

Long-term trend intact

Critical support

17,516

0.7% above

Held this week

Next support

16,516

6.8% above

Where a fresh sell-off could take the index

Nifty 50 shows real strength: up 2.78%

The Nifty 50, India's index of the 50 largest companies, rose 2.78% this week on the weekly price chart and closed at 23,146 on Friday. Last week it broke an 8-week losing streak; this week it built on that.

What happened

Why it matters to us

Large companies rose for a second straight week

A reversal in the Nifty 50 may be starting

The rally was led by large information technology companies

Small companies took part far less

Selling pressure in large companies eased further

Money tends to flow down to smaller companies once large ones stabilise

Further support from the Nifty 50 can limit the selling in the Nifty Smallcap 250 as liquidity improves. Liquidity here means how much money is moving into shares. The small-company index still has to show this on its own chart before we change our stance.

Last week's take, and what changed

Last week (10 October) we said: the index was in a heavy selling zone, only 0.3% above its critical support of 17,516. A break below could take it to 16,516. We advised against fresh money and stayed very selective. The Nifty 50 had just broken its 8-week losing streak with a 0.44% gain, an early positive sign.

This week: the support held. Selling eased, the small-company index posted its first weekly gain in five weeks, and the Nifty 50 followed through with a much stronger week.

What we track

Last week (9 Oct close)

This week (16 Oct close)

Direction

Nifty Smallcap 250

17,575

17,638

Up 0.36%, 5-week losing streak ended

Index vs critical support (17,516)

0.3% above

0.7% above

Support held

Index vs 50-day average

3.4% below

2.9% below

Gap narrowing

Index vs 200-day average

3.9% above

4.1% above

Steady

Nifty 50 weekly return

+0.44%

+2.78%

Stronger

Fresh money

Not recommended

Cautiously Positive

Slight Positive (still holidng cash)

Companies showing relative strength

Two companies on our watchlist and in our portfolio are holding up far better than the index. When the market turns, companies like these are where fresh money is most likely to go first.

Company

What it does

Market value

Price (16 Oct)

Aeroflex Industries

Makes stainless-steel flexible hoses and flow products for aerospace, semiconductor and petrochemical industries

₹6,958 crore

₹525.80

SG Finserve

A non-banking finance company lending to dealers, retailers, vendors and logistics firms in supply chains

₹4,373 crore

₹676.70

Both sit inside our ₹2,000 to ₹30,000 crore range. A strong relative strength line is the first filter, not the decision: each company still goes through our full business review before any fresh money goes in.

These are not recommendations to buy or sell. Empirica India may hold positions in these companies.

Why we watch the Nifty Smallcap 250

We invest mostly in companies with a market value between ₹2,000 crore and ₹30,000 crore. The Nifty Smallcap 250 index is made of exactly this kind of company. When it is healthy, the tide lifts our boats. When it is weak, even good companies find it hard to rise.

We read the index against four moving averages. A moving average is simply the average closing price over the last few days: the 10-day average is the average of the last 10 closes. It smooths out daily noise and shows the direction of travel. We check each one on the daily chart and on the weekly chart.

Average

Time it covers

The question it answers

5-day

About one trading week

Is the mood improving or worsening right now?

10-day

About two trading weeks

Do buyers have short-term control?

50-day

About two and a half months

Is the medium-term trend up?

200-day

About ten months

Is the long-term trend up?

Track the index yourself: Nifty Smallcap 250 chart on TradingView.

Our rulebook: four market conditions

Where the index closes against its 10-day and 50-day averages puts the market in one of four conditions. Each one tells us how we treat fresh money.

Condition

Index vs 10-day

Index vs 50-day

What we do with fresh money

1

Above

Above

Buy our shortlisted companies once we find a good entry point. A healthy market.

2

Above

Below

Buy only companies whose price is stronger than the index, at a good entry point.

3

Below

Above

Same as condition 2.

4

Below

Below

No fresh money. Build and study watchlists of companies showing strength against the index.

Conditions 2 and 3 are not normal buying markets. The direction is unclear, so each company has to earn its place by beating the index first.

Relative strength: is the company beating the market?

Relative strength compares a company's share price with the index, every day. We divide the stock price by the index price and plot the result as a line. Only the direction of that line matters, not its value.

If the line rises, the stock is doing better than the market. If it falls, the stock is doing worse, even when its own price is going up.

We track this line on three charts:

Chart

What it shows

How we use it

Daily

The last few weeks

Timing a good entry point

Weekly

The last several months

Confirming the trend is real

Monthly

The last few years

Checking the long-term leadership story

The strongest case is a line rising on all three charts. Aeroflex Industries and SG Finserve, above, are this week's examples of companies whose line has been rising while the index fell.

What we are doing this week

Selling has eased, but one positive week is not a new trend. Fresh money still waits, and we use this time to sharpen the buy list.

  1. Stay very selective. No new money into equities until the index closes back above its 10-day and 50-day averages, or a company clears the relative strength test on its own.
  2. Follow the Nifty 50. If large companies keep rising, liquidity should improve and the selling in small companies should keep easing.
  3. Track the leaders. We follow companies like Aeroflex Industries and SG Finserve on daily, weekly and monthly relative strength charts.
  4. Check the business. Every company that shows strength goes through our review of earnings, balance sheet, management and valuation.
  5. Mark the entry points. For each company that passes, we note the price levels where we would act once the market turns healthy again.

What would change our view

Signal

Index closes back above its 10-day and 50-day averages and holds there

Condition 1: time to deploy fresh money

Index closes above only one of the two averages

Condition 2 or 3: selective buying only

Index closes below 17,516

Selling resumes; next support at 16,516

Sources


Uddeshya Goel, CFA. This post is for education and explains the framework Empirica India uses internally. It is not a recommendation to buy or sell any security. Empirica India may hold positions in the companies named. Market levels are as of the close on 16 October 2026 and will change. Past patterns do not guarantee future results. Please consult your own adviser before investing.

More from the blog

Empirica Signal: Q2 FY27 Earnings Update, What we purchased this week & Market Health, 12 Nov 2026
Signal 12 Nov 2026 · 4 min read

Empirica Signal: Q2 FY27 Earnings Update, What we purchased this week & Market Health, 12 Nov 2026

Two weeks ago, 13 of our portfolio companies had reported results for July to September 2026 (Q2 of the 2026–27 financial year, or Q2 FY27). Now 22 of 25 have reported, and 11 of them beat our expectations. In the last four trading days the Nifty Smallcap 250 rose about 3% and closed on Thursday above both its 10-day and 50-day averages. By our rules, that is a healthy market to put fresh money to work, and we have started: this week we added to two holdings.

Read more
Empirica Signal: Q2 FY27 earning updates for portfolio companies and market health as on 1st Nov'26
Signal 01 Nov 2026 · 4 min read

Empirica Signal: Q2 FY27 earning updates for portfolio companies and market health as on 1st Nov'26

Results season for the July to September 2026 quarter (Q2 of the 2026–27 financial year, or Q2 FY27) is in full swing. 13 of our 23 portfolio companies have reported. 6 beat our expectations, 4 met them and 3 fell short. The other 10 report in the coming weeks. At the same time, the Nifty Smallcap 250 may be turning lower again after a short pause last week. A fall towards 16,000 is possible, so we are careful with fresh money.

Read more